Armando Rossello

- Full Professor in Medicinal Chemistry (SC 03/D1, SSD CHIM/08), Dipartimento di Farmacia, Università di Pisa.
- President of Course of Quality Control of Pharmaceuticals (Faculty of Pharmacy, University of Pisa, (2009-2011)
- President of Faculty’s Joint Commission of courses CQF/TASA for Career management of students (ex 509, 2011 to date).
- Board of the Job Placement Commission of the University of Pisa.
- President of the Library of the Faculty of Pharmacy (2002-2010).
- Scientific member of the Department of Pharmacy in the board of the Librarian of Medicine-Pharmacy, SBA (2012 to present).
- Board of the Scientific Commission of Area 03 of UniPi 2006-2014 and 2018-2020.
- Member of the MIUR Commission for the confirmation of the role of the University Researcher (SSD CHIM / 08, 2010-2012).
- Evaluator of research programs "BlueSky Program", Agence Nationale de la Recherche (France, 2010).
- Coordinator of Nuclear Magnetic Resonance Laboratory, Department of Pharmacy (2005 to date).
- Affiliate Researcher at the INTERDEPARTMENTAL RESEARCH CENTER FOR HEALTH AND NUTRITION NUTRACEUTICALS “NUTRAFOOD” of University of Pisa.
- Affiliate Researcher at the E. Piaggio Center, Bioengineering and Robotics Research Center, University of Pisa.
- Editorial Board of International Journal of Medicinal Chemistry, Hindawi.
- Referee of many many high impact journals such as JMC, Eur JMC, BMC, BMCL, ChemMedChem, Curr Pharm Des, Curr Med Chem, J Enz Inh Med Chem , Exp Opin Ther Pat , Rec Pat Anti-Canc, Drug Discov , Biochimie, and others.
- Coordinator or Participant in research projects funded by national and international (recent):
- MIUR, PRIN: a) 2003033405_008; b) 2004031241_001, c) 007JERJPC_005; d) 20098SJX4F_003 (Participant); -Bracco SpA, "Inibitori delle Metallo Proteasi (MMPs) quali potenziali farmaci antidegenerativi o carrier nell’imaging di processi degenerativi (tumori, patologie infiammatorie, vascolari o neuro degenerative)" 2007-2009 (Coordinator); -Fondazione Monte dei Paschi [2007, (Member)]; -, [P.I. Prof. Sylte Ingebrigt research Council of Norway, Oslo (2007-2011)] Italian Research Unit, Coordinator (Italy); - "Development of Selective Inhibitors of MMPs", UniPi /CEA, Div Life Science (F), 2011-2013, Coordinator (Italy); - "Enhancement of NKG2DL induced anti-tumor response in Hodgkin’s lymphomas: ERp5 and ADAM10/17 as possible therapeutic targets” AIRC 2012 [HSR, Zocchi, IG 12759], Research Unit, UniPi Scientific Coordinator; -"ADAMs and ERp5 as therapeutic targets to enhance NKG2DL-induced anti-tumor response in Hodgkin lymphoma: development of specific inhibitors", AIRC 2015 [HSR, Zocchi, IG 17074] Research Unit, UniPi Scientific Coordinator; -PRA_2016_27, UniPi Participant; - M-ERA.NET "Bioengineered in vitro model of retinal pigmented epithelium of human eye (BIOMEMBRANE)" Participant, (2017-2019); PRIN-2017XYBP2R: Deciphering the role of Carbonic Anhydrase isoforms in psychiatric disorders, Associated Investigator (2019-2021); Helse Nord [UiT- The Artic University of Norway, Prof. Ingebright Sylte, HNF1514-20]: "Inhibition of Pseudomonas aeruginosa virulence as a putative new strategy against bacterial infection", Associated Investigator (2019-2023).
- Collaboration with numerous University and Industrial research partners both in Italy, England, France, Belgium, Germany, Portugal, Norway and the United States.
- Author of more than 162 publications on high-impact journals and some book chapters in the field of Medicinal Chemistry. (Scopus): 34 (h-i), Citations 3101 (last 15 years); (Google Scholar): Total: 36 (I-h), 102 (i-10 full), 69 (i-10, 2018). s) Patents, Principal Investigator (16).

See at link:

https://arpi.unipi.it/cris/rp/rp11635

https://www.scopus.com/authid/detail.uri?authorId=7004655378